Voloridge Investment Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-26,322
Closed -$450K – 1219
2024
Q1
$450K Sell
26,322
-71,177
-73% -$1.12M ﹤0.01% 1051
2023
Q4
$1.72M Buy
97,499
+48,986
+101% +$987K 0.01% 863
2023
Q3
$1.16M Sell
48,513
-21,206
-30% -$520K 0.01% 1065
2023
Q2
$1.62M Buy
+69,719
New +$1.58M 0.01% 1028
2022
Q1
– Sell
-23,183
Closed -$517K – 1402
2021
Q4
$517K Sell
23,183
-37,629
-62% -$981K ﹤0.01% 1405
2021
Q3
$1.69M Sell
60,812
-36,086
-37% -$1.1M 0.01% 1104
2021
Q2
$3.77M Sell
96,898
-691
-0.7% -$24.8K 0.03% 742
2021
Q1
$2.81M Sell
97,589
-2,986
-3% -$102K 0.02% 693
2020
Q4
$2.67M Sell
100,575
-53,138
-35% -$1.09M 0.02% 642
2020
Q3
$2.35M Buy
153,713
+30,999
+25% +$650K 0.02% 664
2020
Q2
$2.49M Buy
122,714
+11,906
+11% +$213K 0.03% 540
2020
Q1
$1.15M Buy
110,808
+45,439
+70% +$1.27M 0.03% 477
2019
Q4
$2.46M Buy
65,369
+23,295
+55% +$1.05M 0.05% 442
2019
Q3
$1.96M Sell
42,074
-1,604
-4% -$74.6K 0.03% 457
2019
Q2
$2.28M Buy
+43,678
New +$2.56M 0.06% 296

Other funds holding CLB

Voloridge Investment Management's CLB Position: Q2 2024 in Review

Voloridge Investment Management sold out of Core Laboratories (CLB) in Q2 2024, closing a stake of 26,322 shares — an estimated $450K sold.

Voloridge Investment Management first reported a position in CLB in Q2 2019 and held it in 15 quarters. The position peaked at $3.77M in Q2 2021. 194 funds tracked by Wall St. Rank hold CLB as of Q2 2024.

  • Voloridge Investment Management reported no remaining Core Laboratories position as of Q2 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 26,322 Core Laboratories shares in Q2 2024, an estimated $450K.
  • Voloridge Investment Management first reported a position in Core Laboratories in Q2 2019 and held it in 15 quarters.
  • Voloridge Investment Management's Core Laboratories position peaked at $3.77M in Q2 2021.
  • 194 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2024.

Based on Voloridge Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.